Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05577000 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05577000
- Sponsor
- Thomas Martin, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2025-11-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.